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Abstract. 
 
Conventional kinesin, kinesin-I, is a het-
erotetramer of two kinesin heavy chain (KHC) sub-
units (KIF5A, KIF5B, or KIF5C) and two kinesin light 
chain (KLC) subunits. While KHC contains the motor 
activity, the role of KLC remains unknown. It has been 
suggested that KLC is involved in either modulation of 
KHC activity or in cargo binding. Previously, we char-
acterized KLC genes in mouse (Rahman, A., D.S. 
Friedman, and L.S. Goldstein. 1998. 
 
J. Biol. Chem.
 
 273:
15395–15403). Of the two characterized gene products, 
KLC1 was predominant in neuronal tissues, whereas 
KLC2 showed a more ubiquitous pattern of expression. 
To deﬁne the in vivo role of KLC, we generated KLC1 
gene-targeted mice. Removal of functional KLC1 re-
sulted in signiﬁcantly smaller mutant mice that also ex-
hibited pronounced motor disabilities. Biochemical 
analyses demonstrated that KLC1 mutant mice have a 
pool of KIF5A not associated with any known KLC 
subunit. Immunoﬂuorescence studies of sensory and 
motor neuron cell bodies in KLC1 mutants revealed 
that KIF5A colocalized aberrantly with the peripheral 
cis-Golgi marker giantin in mutant cells. Striking 
changes and aberrant colocalization were also observed 
 
in the intracellular distribution of KIF5B and 
 
b9
 
-COP, a 
component of COP1 coatomer. Taken together, these 
data best support models that suggest that KLC1 is es-
sential for proper KHC activation or targeting.
Key words: kinesin • kinesin light chain • Golgi appa-
ratus • intracellular trafﬁcking • gene targeting
 
A
 
XONAL
 
 transport is essential for various cargoes to
move from the neuronal cell body to the synaptic
terminus. Since its discovery in squid axoplasm
(Vale et al., 1985), kinesin has been implicated as one of
many molecular motors likely to be essential for antero-
grade axonal transport. Conventional kinesin, kinesin-I, is
a tetramer of two kinesin heavy chains (KHCs)
 
1
 
 and two
kinesin light chains (KLCs) associated in a 1:1 stoichio-
metric ratio (Johnson et al., 1990). Although much is now
known about the likely functions of KHC (reviewed by
Bloom and Endow, 1994; Moore and Endow, 1996; Gold-
stein and Philp, 1999), little is known about the roles of
KLC. Previous studies suggest that KLCs are required for
either cargo binding (Brady and Pfister, 1991; Stenoien
and Brady, 1997; Khodjakov et al., 1998) or negative regu-
lation of KHC (Hackney et al., 1991; Verhey et al., 1998),
but further information is clearly needed.
In mammals, the polypeptide components of kinesin-I
are encoded by three KHC genes, KIF5A, KIF5B, and
KIF5C (Gudkov et al., 1994; Niclas et al., 1994; Nakagawa
et al., 1997; Xia et al., 1998), and three KLC genes, KLC1,
KLC2, and KLC3 (Lamerdin et al., 1996; Rahman et al.,
1998). The KIF5A, KIF5C, and KLC1 polypeptides are
enriched in neuronal tissues, whereas the KIF5B and
KLC2 polypeptides are more ubiquitously distributed;
KLC3 has not yet been detected. Recent data suggest that
while KHC and KLC only form homodimers amongst
themselves, there is no specificity in the interaction of
KLCs with KHCs (Rahman et al., 1998). The diversity in
the forms and interactions of KHC with KLC may explain
the variability seen in previous kinesin immunolocaliza-
tion, biochemical, and functional studies (Bloom and En-
dow, 1994; Rahman et al., 1998; Goldstein and Philp,
1999).
Previous studies with mutants lacking KHC in inverte-
brate organisms have all given neuronal phenotypes (Sax-
ton et al., 1991; Gho et al., 1992; Patel et al., 1993; Hurd
and Saxton, 1996), suggesting that kinesin-I plays a pri-
mary role in neuronal transport. Mutants lacking KLC in
 
Drosophila melanogaster 
 
(Gindhart et al., 1998) exhibit
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1. 
 
Abbreviations used in this paper:
 
 DRG, dorsal root ganglion; ES,
embryonic stem; KHC,
 
 
 
kinesin heavy chain; KLC,
 
 
 
kinesin light chain;
MannII, mannosidase II; TPR, tetratrico peptide repeat. 
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neuronal phenotypes similar to that seen when KHC is re-
moved. In particular, mutants lacking either KHC or KLC
in 
 
Drosophila
 
 (Saxton et al., 1991; Gindhart et al., 1998)
die at the third larval instar stage with a distinctive paraly-
sis, and show accumulations of an array of molecular mo-
tors and vesicular cargoes in the axons of the segmental
nerves (Gho et al., 1992; Hurd and Saxton, 1996; Gindhart
et al., 1998). Mutations in the 
 
unc-116 
 
gene, which encodes
the 
 
Caenorhabditis elegans
 
 homologue of kinesin-I, re-
sulted in axon mispositioning (Patel et al., 1993). Gene tar-
geting of the ubiquitous KIF5B in mice, however, resulted
in embryonic lethality (Tanaka et al., 1998). To probe fur-
ther the functions of KLC in neurons, we generated and
analyzed mutant mice lacking normal KLC1.
 
Materials and Methods
 
KLC1 Gene Targeting and Chimeric Mouse Production
 
A 129 isogenic genomic library (obtained from Dr. A. Nagy, Samuel
Lunenfeld Research Institute, Toronto, Canada) was screened with the
full-length KLC1 cDNA (Rahman et al., 1998). Various genomic clones
were characterized by restriction digestion followed by Southern analysis.
One clone, g5.1, was determined to contain the translational start site.
This clone was further characterized by extensive restriction digests and
partial sequencing. A 2.5-kb HindIII/PstI genomic fragment was sub-
cloned into pBS II KS (
 
2
 
; Stratagene) as the 3
 
9
 
 flanking arm (pBS-3
 
9
 
). A
1.4-kb BglII/NotI subcloned fragment was digested with EcoRV and
Eco0109, and the smaller 1.2-kB fragment was blunted with Klenow and
subsequently subcloned into the XhoI site of pBS-3
 
9
 
. The resulting target-
ing construct (pBS-5
 
91
 
3
 
9
 
) had both the 5
 
9
 
 and 3
 
9
 
 flanking arms and
unique SalI and NotI sites. The exon that was removed encoded a 72-
amino acid sequence starting at QHSDSSA and ending at NILALVY.
This region contained genomic sequences encoding the 10 amino acids be-
fore the beginning of the first TPR (tetratrico peptide repeat) domain, the
 
entire first TPR domain, and 20 amino acids of the second TPR domain
(Rahman et al., 1998). Removal of this segment of genomic DNA should
result in out of frame translation of the remainder of the KLC1 gene (Fig.
1 A). The 6-kB SalI fragment of pGT-IRES 
 
b
 
-geo (Mountford et al.,
1994), containing the IRES 
 
b
 
-geo cassette, was subcloned into pBS-5
 
91
 
3
 
9
 
to complete the targeting construct (Fig. 1 A). The targeting vector was
linearized using the unique NotI site, and 20 
 
m
 
g of the linearized DNA
was electroporated into R1 embryonic stem (ES) cells as described by
Wurst and Joyner (1993). The ES cells were grown (Wurst and Joyner,
1993) for 2 d before selection with 125 
 
m
 
g/ml of G418 (active weight;
GIBCO BRL) for an additional 10 d. 94 ES cell colonies were isolated and
the fastest growing 67 colonies were checked by PCR for a homologous
recombination event. The 5
 
9
 
 PCR primer (CTAATTTTGGACTTC-
CAGCAAAGAC) encoded KLC1 genomic DNA sequences residing
outside the targeting vector. The 3
 
9
 
 primer (TACACCTGGCCAGT-
GAGGCTTCTA), used for PCR, encoded sequences within the en-2 re-
gion of the IRES 
 
b
 
-geo cassette. The resulting PCR product is 
 
z
 
1.4 kb. Of
the initial 67 clones checked, 6 gave PCR products of the expected size.
These clones (A1, A2, E2, F1, F11, and H4) were verified as homologous
recombinants by Southern analysis of SacI digested genomic DNA. The
probe used was a 240-bp SacI/BglII fragment adjacent to the targeted se-
quences. Clones that tested positive for recombination events were
trypsinized to single cell state and microinjected into 3.5-d C57BL/6 em-
bryos to produce chimeric mice.
 
DNA Preparation from Tails for Genotyping Mice
 
Tips of tails were isolated from mice between 2–3 wk old. The tail tips
were digested overnight at 55
 
8
 
C in tail lysis buffer (50 mM Tris-HCl, pH
8.0, 50 mM EDTA, pH 8.0, 0.5% SDS, and 0.25 mg/ml proteinase K).
DNA was purified by a single phenol/chloroform extraction, ethanol pre-
cipitated, and resuspended in 100 
 
m
 
l of 10 mM Tris, pH 8.0, 1 mM EDTA.
Genotyping was done by PCR using two sets of primers within one reac-
tion. The first set of PCR primers amplified an 800-bp fragment from the
LacZ region of the targeted gene. The sequences for these primers are as
follows: 5
 
9
 
-GCATCGAGCTGGGTAATAAGCGTTGGCAAT, 3
 
9
 
-GAC-
ACCAGACCAACTGGTAATGGTAGCGAC. The second set of prim-
ers amplified a region (210 bp) across the deleted exon of the KLC1 gene.
The 5
 
9
 
 primer (CGGGCTGTTTCTCTTGGCTTGCTC) encoded se-
Figure 1. Generation of
KLC1 gene-targeted mice. A,
Restriction enzyme map of
the genomic DNA of KLC1
and the resulting targeting
vector. Arrowheads indicate
location of PCR primers for
detecting homologous recom-
bination events. Restriction
enzyme sites are as follows:
H, HindIII; S, SacI; X, XbaI;
B, BglII; EV, EcoRV; E,
EcoR0109; P,  PstI; and N,
NotI. The thicker black boxes
represent exons. B, Southern
analysis of clones that tested
positive by PCR for recombi-
nation events. The recombi-
nation event produces a
larger SacI fragment when
probed with a 240-bp SacI/
BglII fragment residing out-
side the targeting vector. The
clones A1, A2, E2, F1, F11,
and H4 all tested positive for
a recombination event. A4 is
another G418 resistant col-
ony that was not positive for homologous recombination at the correct locus. Germline transmission was obtained from lines E2 and
F11. C, Offspring from matings of KLC1 heterozygous mice were genotyped by PCR. PCR was performed on genomic DNA isolated
from mouse tail clippings. Primers were designed to amplify 800- and 210-bp fragments for the recombinant and wild-type KLC1 genes,
respectively. 
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quences within the 5
 
9
 
 short flanking arm of the targeting vector. The 3
 
9
 
primer (GGAGCGTGCGCAGCCTTGCAGGGA) encoded sequences
in the deleted exon of the KLC1 gene. PCR conditions were as follows:
denaturation at 94
 
8
 
C for 10 min, 35 cycles of denaturation at 94
 
8
 
C for 1
min, annealing and elongation at 72
 
8
 
C for 4 min, and a 10-min final elon-
gation at 72
 
8
 
C.
 
Characterization of Visible Phenotype of Mice
 
All 98 offspring from the first 12 litters of heterozygous 
 
3
 
 heterozygous
matings were weighed at 10, 14, 18, and 21 d after birth. The pups were ear
punched at day 10 to distinguish them from each other. Genotyping was
done as described. 25 sets of adult mice that were caged together were
also weighed after 
 
z
 
1 yr of age as a final data point.
15 sets of mice (wild-type, heterozygous, and homozygous) were also
tested for sensorimotor defects. Essentially, mice were allowed to hang
upside down from chicken wire (1-cm gauge) attached to a bell jar 
 
z
 
1.5–2
ft above a surface. They were subsequently timed until they fell off. Tim-
ing was cut off at 2 min of hanging upside down.
 
Biochemical Analyses
 
Western analysis was done as described by Rahman et al. (1998). Essen-
tially, a whole brain from either a 6-wk-old wild-type, heterozygous, or
homozygous mouse was homogenized in PBS (140 mM NaCl, 2.5 mM
KCl, 10 mM Na-phosphate dibasic, 2 mM K-phosphate monobasic, pH
7.4) with protease inhibitors. The crude lysate was centrifuged at 3,000 
 
g
 
and the supernatant quantitated for total amount of protein by Bradford
analysis (BioRad). Equivalent amounts of total protein were loaded per
lane on 10% polyacrylamide gels. Western analysis was done with mAb
63-90 (1:1,000 dilution of ascites fluid; Stenoinen and Brady, 1997), poly-
clonal antisera directed against KLC1 and KLC2 (Rahman et al., 1998),
polyclonal antisera directed against KIF5A (1:100 dilution), polyclonal
sera directed against KIF5B (1:1,000 dilution; Niclas et al., 1994), or an
mAb to actin (1:5,000 dilution; Boehringer Mannheim Catalog #1 378
996). Bands were visualized by incubating with either HRP-conjugated
goat anti–rabbit IgG (Zymed Labs, Inc.) or goat anti–mouse IgG (Jackson
ImmunoResearch Laboratories, Inc.) secondary antibodies, and subse-
quent processing with ECL (Nycomed Amersham Inc.).
For quantitative Western blot analysis of protein amounts, the antibod-
ies were first calibrated to give linear detection of signals over a linear di-
lution range (10–50 
 
m
 
g of the brain supernatant/lane). Equal amounts
(40 
 
m
 
g) of brain supernatant were loaded for the wild-type, heterozygous,
and mutant KLC1 samples and probed with the above antibodies. Band
intensities were quantitated using NIH Image and relative ratios of the in-
tensities were calculated.
For sucrose gradient analysis of kinesin-I, brain from either a 6-wk-old
wild-type, heterozygous, or homozygous mouse was homogenized in
buffer A (10 mM Hepes, pH 7.3, 0.5 mM EGTA, 0.5 mM MgCl
 
2
 
, 50 
 
m
 
M
ATP) in the presence of protease inhibitors. The crude lysate was centri-
fuged at 3,000
 
 g 
 
to remove unbroken cells and nuclei, and the postnuclear
supernatant subsequently centrifuged in a Sorval T-1270 rotor at 35,000
rpm for 30 min at 4
 
8
 
C. The resulting high-speed supernatant (0.4 ml) was
then top-loaded onto a 5–20% linear sucrose gradient (10.4 ml in buffer
A), and centrifuged in a Beckman SW41 rotor at 39,000 rpm for 14 h. 16
fractions (
 
z
 
0.6 ml each) were collected from the top of the gradient using
a fraction collector. Equal volumes of each fraction were loaded onto 10%
SDS polyacrylamide gels, and quantitative Western analysis done as de-
scribed. Control protein markers, alcohol dehydrogenase (7.4 S), catalase
(11.3 S), and 
 
b
 
-galactosidase (16 S) were solubilized and centrifuged in
parallel sucrose gradients, and the enzymatic activities measured in each
fraction (Martin and Ames, 1961) to determine the peak of each marker.
 
Immunoprecipitation Reactions
 
Immunoprecipitation reactions were carried out as described by Rahman
et al. (1998). Whole brains from 6-wk-old wild-type, heterozygous, and
homozygous mice were homogenized in 1 ml of RIPA buffer (150 mM
NaCl, 50 mM Tris, pH 8.0, 1% NP-40, 0.5% deoxycholate, 0.1% SDS)
with protease inhibitors. The homogenates from brain from each type of
mouse were spun at 100,000 
 
g
 
 for 30 min to yield lysate. 100 
 
m
 
l of lysate
was precleared with preblocked protein A–Sepharose beads (Zymed
Labs, Inc.) and subsequently used for immunoprecipitation reactions. Suf-
ficient quantities of either anti-KLC1 and anti-KLC2 (Rahman et al.,
1998), or anti-KIF5A and anti-KIF5B antibodies (Niclas et al., 1994) were
added to the precleared lysate so as to completely immunoprecipitate the
 
antigens in the lysate. The antibody–protein complex was precipitated
with protein A–Sepharose beads (Zymed Labs, Inc.). The beads were
washed several times with RIPA buffer, once with 50 mM Tris, pH 6.8,
and resuspended in 2
 
3
 
 SDS loading buffer. Equivalent volumes of lysates
and immunoprecipitates, and supernatants from immunoprecipitates were
loaded in each lane and subsequently analyzed by Western blotting as de-
scribed.
 
Immunofluorescence Studies
 
Immunofluorescence was done as described by Rahman et al. (1998). 6-wk
and older wild-type, heterozygous, and homozygous sets of mice were per-
fused with 4% paraformaldehyde and the spinal cord and dorsal root gan-
glion (DRG) were surgically removed. All tissues processed for immuno-
fluorescence were postfixed for 2 h and then transferred to 30% sucrose in
PBS overnight for cryoprotection. 10–14-
 
m
 
m cryosections were prepared
for immunostaining. Primary antibodies were added to a buffer containing
1
 
3
 
 PBS, detergent (either 0.6% Triton X, 1% Triton X, or 0.15% sapo-
nin), and 5% BSA for overnight incubations. Antibodies against KLC1
and KLC2 were used at a final concentration of 100 
 
m
 
g/ml. KIF5A and
KIF5B antibodies (Niclas et al., 1994) were used at 1:50 and 1:20 dilutions,
respectively. 63-90 (Stenoien and Brady, 1997) was used at a 1:250 dilution
of the ascites fluid. Giantin (Linstedt and Hauri, 1993) was used at a 1:50
dilution of supernatant. Monoclonal 
 
b9
 
-COP antibody (CMIA10) was
used at a dilution of 1:2,000 (Orci et al., 1993; Lowe and Kreis, 1996). Flu-
orescein-conjugated sheep anti–rabbit IgG (2 
 
m
 
g/ml) and Texas red-
labeled goat anti–mouse IgG (2.5 
 
m
 
g/ml), or fluorescein-conjugated sheep
anti–mouse IgG (2 
 
m
 
g/ml) and Cy5-conjugated goat anti–rabbit (2 
 
m
 
g/ml)
secondary antibodies were used for visualizing staining. A BioRad MRC-
1024 confocal laser scanning microscope was used to collect images.
 
Sciatic Ligations
 
The sciatic nerves of anesthetized mice were ligated as described in Smith
(1980), Hirokawa et al. (1990), and Hanlon et al. (1997). After a 6-h liga-
tion, the mice were transcardially perfused with 4% paraformaldehyde
and both the ligated and unligated sciatic nerves were removed from the
mouse. The tissue was subsequently processed for immunofluorescence
as described above. All mice used for these ligation experiments were
 
z
 
6-wk-old.
 
Results
 
Generation of KLC1 Mutant Mice
 
To analyze KLC1 function, we generated mice with a
gene-targeted mutation in the KLC1 gene. The construc-
tion of a true null mutation in this gene was complicated
by instability of the 5
 
9
 
 region of the KLC1 gene in plasmid
vectors. Thus, a KLC1 targeting construct that removed
the entire gene could not be made. Instead, we made a
construct (Fig. 1) that removed the majority of the gene,
including the region encoding the highly conserved TPR
domain (Gindhart and Goldstein, 1996), and left only a
small piece encoding the alpha-helical coiled coil needed
for interaction with KHC (Gauger and Goldstein, 1993;
Diefenbach et al., 1998). Although a small amount of the
encoded KLC1 fragment could be detected under some
conditions, several lines of evidence discussed here suggest
that this mutant is functionally null.
The promoterless IRES-
 
b
 
-geo targeting vector was used
to enrich for homologous recombination at the correct lo-
cus. The targeting frequency observed with KLC1 was
 
z
 
10%. Six clones were obtained that tested positive for
recombination by PCR and Southern analysis (Fig. 1 B).
Of these six clones, E2 and F11 produced mice that were
highly chimeric (
 
.
 
50% coat color contribution from ES
cell lineage). All highly chimeric male mice obtained from
the E2 and F11 lines were able to transmit through the 
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germline, as observed by agouti coat color of the offspring
from C57BL/6 matings. However, two of these male chi-
meric mice consistently transmitted to offspring at 
 
.
 
90%
efficiency. Since homologous recombination only affects
one copy of the targeted gene, agouti coat color by itself is
not an indication of a heterozygous mouse. Therefore, all
agouti offspring from chimera and C57BL/6 or 129 SvEv
matings were genotyped by PCR (Fig. 1 C). The first 100
genotypings were also done in tandem with dot blots using
a 
 
b
 
-galactosidase probe to verify reproducibility of the
PCR reactions (data not shown). Heterozygous mice did
not display any discernible abnormalities and were indis-
tinguishable from their wild-type littermates. Heterozy-
gous mutant mice were interbred to produce homozygous
mice. All offspring from matings of heterozygous mice
were genotyped by PCR (Fig. 1 C).
 
General Observations of Mutant Mice
 
PCR genotyping of mouse tails from offspring of matings
of heterozygous mice showed that homozygous KLC1 mu-
tant mice are viable (Fig. 1 C). These mice are, however,
significantly smaller than their wild-type or heterozygous
littermates (Fig. 2, A and C). All offspring from the first 12
litters (98 mice total) were sexed, genotyped, and weighed
periodically until weaning at 21 d after birth. In a mixed
129/BL6 background, the predicted Mendelian ratio of 1:2:1
was observed of wild-type (KLC1 
 
1
 
/
 
1
 
;
 
 n 
 
5 
 
25/98), het-
erozygous mutant (KLC1 
 
1
 
/
 
2
 
;
 
 n 
 
5 
 
54/98), and homozy-
gous mutant (KLC1 
 
2
 
/
 
2
 
;
 
 n 
 
5 
 
19/98) animals. A 1:1 ratio
of male (n
 
 5 
 
51/98) to female (n
 
 5 
 
47/98) mice was also
observed. Although mice were first weighed, genotyped,
and ear punched for tracking purposes at day 10 after
birth, mice of noticeably small size were evident at birth
and presumed to be homozygous mutant, although they
were too young to be genotyped. The size difference be-
tween wild-type or heterozygous and homozygous mice
was also noticeable in adults (Fig. 2 A). Besides the size
difference, KLC1 mutant mice also exhibited visible motor
defects. One such deficit was quantitated by testing the
ability of the mice to hang upside down from chicken wire
(Fig. 2 B). Heterozygous mutant mice were normal for ev-
ery metric we tested, indicating that the KLC1 mutation is
recessive.
 
Abundance of KLC and KHC in KLC1 Mutants
 
To verify the absence of normal KLC1 in gene-targeted
mice, and to assess the effects of removing normal KLC1
on the behavior of KLC2, KIF5A, and KIF5B, Western
analysis of brain and sciatic nerve tissue homogenates was
done. The abundance of each of these proteins was com-
pared between littermates that were wild-type, heterozy-
gous mutant, and homozygous mutant. Careful quantita-
tion using actin as an internal control standard revealed no
discernible difference in the levels of either KIF5A or
KIF5B in crude cytoplasmic lysates of brain from each of
the three genotypes (Fig. 2 D and Table I). KLC1 and
KLC2 levels in brain were assessed with mAb 63-90
(Stenoien and Brady, 1997), which is an mAb that recog-
nizes a shared epitope in the coiled-coil region of both
KLC1 and KLC2. Hence, it should recognize both full-
Figure 2. Analysis of basic
phenotypes of KLC1 mutant
mice. A, All 98 offspring
from the first 12 litters of F1
heterozygous 3 F1 heterozy-
gous matings were weighed
at days 10, 14, 18, and 21 after
birth. 25 adult mice of each
genotype (caged together)
were also weighed at z1 year
of age as a final data point.
The average weights in each
category are represented in
this graph. Homozygous mice
were consistently smaller
than their heterozygous or
wild-type littermates. B, 15
wild-type, heterozygous, and
homozygous mice were
tested for sensorimotor de-
fects. Mice were allowed to
hang upside down from
chicken wire (1-cm gauge) at-
tached to a bell jar z1.5–2 ft
above a surface. They were
subsequently timed until they
could no longer maintain grip and fell. Timing was cut off at 2 min for wild-type and mutant heterozygotes. C, Picture of wild-type and
homozygous mice from the same litter at z3-wk old. The wild-type mouse (agouti coat color) is noticeably larger than the KLC1 ho-
mozygous mouse (black coat color). D, Equal amounts of total protein (40 mg) from brain extracts were loaded for Western analysis.
KIF5A and KIF5B antibodies were used to detect the two KHC components, and 63-90 was used to detect both KLC2 (upper band)
and KLC1 (lower band). Actin was used as an internal loading control for the blots. The intensity of the bands was quantitated using
NIH Image and the ratios calculated as shown in Table I. 
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length and truncated KLC1 with comparable affinity. The
levels of KLC1, but not KLC2, were dramatically reduced
in crude cytoplasmic brain extracts from KLC1 
 
2
 
/
 
2
 
 mice
(Fig. 2 D and Table I). A very small amount of the trun-
cated KLC1 protein product could also be detected. The
lack of any measurable change in the amounts of KIF5A
and KLC2 in KLC1 mutants suggests that there is a pool
of KIF5A that is not associated with any KLC in KLC1
mutants; this supposition is confirmed by the sucrose gra-
dient analysis described below. In sciatic nerve extracts, no
obvious changes were observed in the levels of KIF5A,
KIF5B, or KLC2 (data not shown). Similar to what was
observed with brain extracts, only a small amount of the
KLC1 fragment could be detected in sciatic nerve extracts
from mutant animals. Interestingly, immunofluorescence
with both anti-KLC2 and mAb 63-90 suggest that KLC2
levels are reduced in the sensory neuron cell bodies of the
DRG from mutant animals. However, levels of KLC2 did
not seem to be affected much in the cell bodies of the mo-
tor neurons in the ventral horn of the spinal cord (data not
shown). As described previously, KLC3 could not be reli-
ably detected (Rahman et al., 1998).
 
Interactions of KIF5A and KIF5B with KLC in
Wild-type and KLC1 Mutants
 
To assess interactions of wild-type and mutant KLC1 with
KIF5A and KIF5B, to test directly for a pool of KIF5A
free of KLC, and to determine if there was obvious com-
pensation of KLC1 function by KLC2, immunoprecipita-
tion studies combined with Western analyses and sucrose
gradient analyses of brain extracts were conducted. Immu-
noprecipitations with anti-KIF5A and KIF5B antibodies
from brain lysates indicate that KLC2 is still capable of
forming complexes with either KIF5A or KIF5B in KLC1
mutant mice (Fig. 3 A). There was no obvious difference
in the amount of KLC2 that coprecipitated with KIF5A or
KIF5B between wild-type, heterozygous, and homozygous
KLC1 mutant mice; normal KLC1 and the KLC1 fragment
were not detected in homozygous mutant immunoprecipi-
tations. Although the level of truncated KLC1 is greatly
reduced in mutant brain, this observation suggests that
only a small amount of KIF5A or KIF5B, if any, is associ-
ated with the KLC1 fragment.
Sucrose gradient analysis (Fig. 3 B) was used to test di-
rectly the supposition that KLC1 mutants have a pool of
KIF5A lacking KLC that is not ordinarily found in wild-
type. Quantitative Western blotting of sucrose gradient
fractions of mutant and wild-type brain extracts revealed
that in wild-type, all KIF5A sedimented in fractions con-
taining KLC1 and KLC2. The KLC1 mutant, however,
showed a consistent shift in sedimentation of KIF5A to
lighter fractions with significantly less KLC present. Simi-
lar, though not as extreme, behavior of KIF5B was also
 
Table I. Relative Ratios of Kinesin-I Subunits in Wild-type and 
KLC1 Mutants
 
1
 
/
 
11
 
/
 
22
 
/
 
2
 
KLC1:Actin 0.60 0.35 0.00
KLC2:Actin 0.74 0.78 0.74
KIF5A:Actin 0.74 0.80 0.74
KIF5B:Actin 0.88 0.93 0.91
KLC1:KLC2 0.80 0.44 0.00
KIF5A:KLC2 1.00 1.02 1.00
KIF5B:KLC2 1.19 1.18 1.23
Figure 3. Biochemical analysis of KLC1 mutant mice. A, KIF5A
or KIF5B antibodies were used in immunoprecipitation experi-
ments and then probed with KIF5A, KIF5B, or 63-90 antibodies
to assess the association of KHC and KLC forms in wild-type,
heterozygous, and homozygous mutant genotypes. B, Sucrose
gradient analysis of high-speed supernatant of brain extracts
from wild-type (open circles) and mutant KLC1 (closed circles)
was done using 5–20% linear sucrose gradients. 16 fractions were
collected (fraction 1 is top of gradient), and equal volumes were
loaded for Western analysis. The relative intensity of the bands in
each fraction was calculated as described in Fig. 2 D and plotted.
Control protein markers were run in parallel gradients; the en-
zyme activity of alcohol dehydrogenase (7 S) was at fraction 6,
catalase (11.3 S) was at fraction 9-10, and b-galactosidase (16 S)
was at fraction 13-14 (data not shown). 
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seen. This difference presumably arises because KIF5B is
expressed in nonneural cells where KLC1 is ordinarily less
abundant, whereas KIF5A is expressed primarily in neural
cells in which KLC1 expression is enhanced. Finally, we
observed some KIF5A and KIF5B that sedimented at
much higher S values in KLC1 mutants. The origin of this
species is unknown at present, although it could represent
an aggregated component.
 
Alterations in Distribution of KIF5A, KIF5B, and 
COPI in Cell Bodies of the Motor and Sensory Neurons
 
To examine the distribution of KLC and KHC in neuronal
cell bodies, and to evaluate whether loss of normal KLC1
led to changes in the behavior of the KIF5A and KIF5B
subunits of kinesin-I, immunofluorescence studies were
carried out. Motor neuron cell bodies in the ventral horn
of the spinal cord and sensory neuron cell bodies in the
DRG were examined. In KLC1 mutant homozygotes,
KIF5A was seen to accumulate abnormally in tubular
structures in both the motor neuron cell bodies (Fig. 4 A)
and the sensory neuron cell bodies in the DRG (Fig. 4 B).
To determine if the aberrant localizations of KIF5A corre-
sponded to known membrane compartments, motor neu-
ron cell bodies were double labeled with KIF5A antibod-
ies and a variety of other antibody markers for the ER,
Golgi apparatus, lysosomes, and mitochondria. Interest-
ingly, the aberrant KIF5A staining in the motor neuron
cell bodies of the ventral horn was seen to colocalize only
with the cis-Golgi marker giantin in KLC1 homozygous
mice and not with other markers tested (Fig. 4 A). Similar
colocalization of KIF5A and giantin was seen in sensory
neuron cell bodies of the DRG (Fig. 4 B). To confirm
that giantin probes were labeling cis-Golgi compartment
as expected, double labeling with antibodies directed
against the well characterized Golgi marker mannosidase
II (MannII) were done; precise colocalization of MannII
and giantin was observed (Fig. 5 A). Finally, KLC1 mutant
neuronal cells did not exhibit any obvious changes in ei-
ther mitochondrial or steady-state lysosome distribution
visualized by immunofluorescence (data not shown).
Mice that were heterozygous for the KLC1 mutation
showed a primarily diffuse staining pattern of KIF5A in
both motor and sensory neuron cell bodies (Fig. 4 C), sug-
gesting that the small amount of KLC1 fragment does not
actively induce abnormal behavior of KIF5A. Similar to
wild-type animals, only faint staining by KIF5A antibodies
in or near the Golgi apparatus was seen in the motor and
sensory neurons of heterozygous mutant animals.
KLC2 staining (Fig. 5 B) levels were consistently re-
duced in the sensory neuron cell bodies of KLC1 mutant
mice. In addition, the strong and diffuse KLC1 staining or-
dinarily seen in wild-type was not observed in the cell bod-
ies of homozygous mutant sensory (Fig. 5 C) and motor
neurons (data not shown), confirming that normal KLC1
was gone and that the KLC1 fragment was virtually absent
from the cell bodies. The combined Western and staining
data thus suggest that the truncated KLC1 protein levels
are dramatically reduced in the cell bodies, compared with
wild-type levels of KLC1. Neither mAb 63-90 or poly-
clonal KLC1 antibodies showed any costaining of the
KLC1 fragment and giantin or KIF5A in homozygous
Figure 4. Abnormal accumu-
lation of KIF5A on Golgi
structures in KLC1 mutants.
A, Abnormal localization of
KIF5A in the motor neuron
cell bodies on structures that
costain with the peripheral
cis-Golgi marker, giantin.
KIF5A staining is diffuse in
wild-type cells, but accumu-
lates on structures staining
for a Golgi marker in KLC1
mutants. B, KIF5A localiza-
tion in or near structures
staining for giantin in KLC1
mutants is also observed in
the cell bodies of sensory
neuron in the DRG. C, There
are no detectable differences
in the staining pattern of
KIF5A between wild-type
and heterozygous DRG sen-
sory and motor neurons.
Bars, 10 mm.  
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KLC1 mutant cells. KIF5B staining was also altered in ho-
mozygous KLC1 mutant sensory, but not in motor neuron
cell bodies; the normal diffuse pattern was altered to a
more punctate distribution (Fig. 5 D) that did not colocal-
ize with known ER, mitochondrial, or Golgi markers (data
not shown). Intriguingly, COPI distribution detected by
mAb CM1A10 staining of 
 
b9
 
-COP (Lowe and Kreis, 1996)
in sensory neuron cell bodies was also altered by the lack
of functional KLC1. The staining pattern changed from
one that resembled Golgi apparatus staining in wild-type
sensory cells to a more punctate staining pattern in KLC1
mutant cells (Fig. 5 E). The altered CM1A10 staining largely
colocalized with the aberrant KIF5B staining (Fig. 5 F).
 
Accumulation of KIF5A and KIF5B in Sciatic
Nerve Ligations
 
To gain a qualitative assessment of KIF5A and KIF5B be-
havior in axonal transport, we used sciatic nerve ligation
experiments. Sciatic nerve ligation is a unique way of visu-
alizing directional movement along microtubules. Micro-
tubules within the axons of the sciatic nerve are arranged
such that their minus end is toward the cell body and the
plus end is towards the synaptic terminal. Hence, accumu-
lations of motor proteins proximal to the site of ligature
indicate plus end directed movement, whereas accumula-
tions on both sides of the ligature usually indicate minus
end directed movement (Hirokawa et al., 1990, 1991; Han-
lon et al., 1997). Ligation experiments indicate that KIF5A
and KIF5B are able to move in a plus end directed fashion
in KLC1 mutant mice (Fig. 6). There were no discernible
differences between accumulations in wild-type, heterozy-
gous, and homozygous mutant KLC1 mice.
 
Discussion
 
Mice lacking wild-type KLC1 are abnormal. These mice
exhibit overt movement defects, small size, and in particu-
lar, their sensory and motor neurons have obvious alter-
ations in the intracellular localization of kinesin-I and
COP-I components. Together, these data demonstrate
that KLC1 has crucial functions, even in the presence of
the potentially redundant KLC2 and KLC3. To under-
stand fully the phenotype of the KLC1 mutant that we
generated, and its implications for the intracellular func-
tion of KLC1, it is necessary to evaluate the nature of the
KLC1 mutation that we made.
There are several lines of evidence that support the view
that the KLC1 mutation we made is functionally null with
respect to the phenotypes observed, in spite of the pres-
ence of a KLC1 fragment of low abundance. First, West-
Figure 5. Immunofluores-
cence studies of sensory neu-
ron cell bodies of the DRG.
A, Giantin recognizes similar
structures as MannII in DRG
sensory neuron cell bodies.
B, There is a marked deple-
tion of KLC2 in cell bodies
of sensory neurons of the
DRG in KLC1 mutant mice.
The punctate perinuclear
staining observed in KLC1
2/2 cells is also detected in
wild-type cells, although not
as clearly because of the en-
hanced cytoplasmic staining.
C, KLC1 staining in wild-
type, heterozygous, and ho-
mozygous KLC1 mutants. D,
KIF5B staining changes from
an overall diffuse pattern in
wild-type cells to a punctate
form in KLC1 2/2 cells. E,
b9-COP (COP1) staining as
visualized by CM1A10 is dis-
rupted in KLC1 mutant
mice. The staining pattern
with CM1A10 resembles
Golgi apparatus-like struc-
tures in wild-type cells, how-
ever, this pattern becomes
punctate in KLC1 mutant
cells. F, Colocalization of
KIF5B and b9-COP
(CM1A10) in aberrant accu-
mulations in KLC1 mutants.
Bars, 10 mm.The Journal of Cell Biology, Volume 146, 1999 1284
ern blots of brain tissue from mutant animals suggest that
only a very small amount of the KLC1 fragment relative to
wild-type KLC1 is present. Second, immunofluorescence
of sensory and motor neuron cell bodies in DRG and spi-
nal cord reveals only faintly detectable staining of the
KLC1 fragment relative to the robust staining ordinarily
seen in wild-type. Third, immunoprecipitation experi-
ments from whole brain provide no evidence for the asso-
ciation of the KLC1 fragment with KIF5A or KIF5B.
Fourth, the sites of aberrant accumulation of KIF5A or
KIF5B in DRG or spinal cord do not exhibit costaining
with KLC antibodies in mutants, suggesting that the aber-
rantly behaving KHC chains do so as a result of the ab-
sence of KLC, rather than an active influence of the KLC1
fragment. Fifth, the overall abundance of KIF5A and
KLC2 are unchanged, even though KLC1 has been re-
moved. Thus, there appears to be a larger than normal
pool of KIF5A lacking associated KLC, a suggestion that
was confirmed by sucrose gradient analysis. Sixth, het-
erozygotes are normal with respect to all phenotypes we
observed, suggesting that the fragment does not actively
exert cellular effects. It remains formally possible that the
low abundance KLC1 fragment does have some residual
function, but if so, we have failed to detect it.
Together, the data on the KLC1 mutant mice provide
new insight into the potential functions of KLC. In partic-
ular, they provide new information about organismal re-
quirements for KLC function, and provide new insights
into the role of KLC in kinesin-I function.
KLC1 Function Is Required for Proper Development
Kinesin-I isolated from most species has a 1:1 stoichiomet-
ric ratio of KHC and KLC. However, studies in Neuro-
spora crassa (Steinberg and Schliwa, 1995) show that KLC
proteins do not copurify with KHC in biochemical prepa-
rations. Studies in sea urchin also suggest that stoichiomet-
ric amounts of KLC do not always copurify with KHC
(Skoufias et al., 1994). These results raise the possibility
that KLC function may be most important in a subset of
kinesin-I processes in larger organisms or large cells. This
view seems plausible, given that flies (Gauger and Gold-
stein, 1993), worms (Fan and Amos, 1994), sea urchin
(Wedaman et al., 1993), and squid (Beushausen et al.,
1993) have a single gene encoding KLC, whereas mam-
mals (Lamerdin et al., 1996; Rahman et al., 1998) have at
least three genes encoding KLC. Nonetheless, KLC1 mu-
tants have a constellation of visible phenotypes, even
though KLC2 is clearly present. The KLC gene products
in mammals may have different roles, which partially over-
lap, in intracellular transport in neuronal cells.
Given the strong neuronal phenotype and ultimate le-
thality of mutants lacking KHC or KLC in Drosophila and
mutants lacking KHC in C. elegans, one might expect se-
vere neuronal abnormalities in animals bearing mutant
KLC1. Although KLC1 mutant mice were significantly
smaller than their heterozygous or wild-type siblings and
showed some neuronal deficits, they did not exhibit neu-
ronal problems as severe as those seen in Drosophila.
One explanation for this apparent discrepancy is that al-
though KLC1 is predominantly expressed in tissues of
neuronal origin, these tissues also express KLC2, and pos-
sibly KLC3. Thus, loss of KLC1 may reduce the overall
pool of functional KLC below some necessary threshold,
but otherwise KLC2, or perhaps KLC3, can carry out the
specific functions that KLC1 ordinarily has. A second ex-
planation is that Drosophila axons are of much smaller
caliber than the mouse axons, and hence, a defect leading
to diminished cargo transport in a smaller axon might ac-
tually cause significant blockage of any type of fast trans-
port within that axon. In fact, both KLC and KHC mu-
tants in Drosophila exhibit membranous clogs in the
segmental nerves (Hurd and Saxton, 1996; Gindhart et al.,
1998). A variety of fast transport motors and cargoes are
seen to colocalize in the clogs, suggesting that they may
impair multiple pathways of axonal transport. A mouse
Figure 6. Sciatic nerve ligations detect plus end
directed movement of both KIF5A and KIF5B
in KLC1 mutant mice. Accumulations on the
proximal side of the ligations were comparable
between wild-type, heterozygous, and mutant
mice. Bar, 100 mm.Rahman et al. Kinesin Light Chains in Mouse 1285
axon may be able to overcome this blockage problem by
having more volume to accommodate membranous accu-
mulations. Hence, lethality due to null mutations of KHC
and KLC in Drosophila may be a secondary phenotype
due to the physiology of the organism, rather than because
of a crucial requirement for certain cargoes to be trans-
ported by kinesin-I. A third explanation is that KLC1 may
be required for a subset of kinesin-I molecules in the cell
to transport unique cargoes, but the transport of these car-
goes is not essential for neuronal viability. Further work is
needed to distinguish among these possibilities.
Cellular Effects of Loss of KLC
The most plausible explanation for the cellular phenotype
observed in KLC1 mutant mice is that a subset of kinesin-I
holoenzyme function is disturbed in KLC1 mutant mice.
The abnormal accumulations of KIF5A and KIF5B may
reflect either blocks in some nonessential transport pro-
cesses that require KLC1, kinetic accumulations resulting
from reduced rates of some events, or accumulations at
abnormal sites. Although KIF5C was not analyzed owing
to a lack of appropriate reagents at the time these experi-
ments were conducted, we presume that future work will
find that its behavior is altered as well. It is unclear why
the cellular distribution of KIF5A is perturbed in both
sensory and motor neurons whereas the cellular distribu-
tion of KIF5B is only detectably perturbed in sensory neu-
rons. Whether these cell-type specific differences reflect
divergent roles of KIF5B in motor and sensory neurons or
a different balance between active and inactive states is
unknown at present.
Previous studies have indicated that kinesin-I may play
roles in a variety of different cellular processes, e.g., traf-
ficking between the Golgi apparatus and the ER (Lippin-
cott-Schwartz and Cole, 1995), mitochondrial placement
(Khodjakov et al., 1998; Tanaka et al., 1998), lysosomal
movement (Hollenbeck and Swanson, 1990; Tanaka et al.,
1998), and perhaps late events in the secretory pathway.
Double labeling experiments indicated that accumulations
of KIF5A in sensory and motor neuron cell bodies colocal-
ized with the cis Golgi marker giantin. This observation is
consistent with the hypothesis that kinesin-I plays some
role in transport events involving, or initiating, at the
Golgi apparatus. Interestingly, b9-COP staining was also
radically redistributed in sensory neuron cell bodies in
KLC1 mutant animals. Therefore, the redistribution of b9-
COP in the mutant DRG cells may be caused by some dis-
turbance in the rate or character of transport between
Golgi apparatus and ER, or perhaps interference by the
aberrant accumulations of KIF5A or KIF5B. It is unlikely,
however, that there is an absolute block in these events,
since the mice are viable and the Golgi apparatus has a
grossly normal organization and distribution in these
cells. KLC1 mutant neuronal cells also did not exhibit any
obvious changes in either mitochondria or steady state ly-
sosome distribution by immunofluorescence studies (data
not shown), although KIF5B localization was abnormal.
These differing observations suggest that neuronal and
ubiquitous forms of kinesin-I may have distinct pathways
of activity that do not fully overlap, and may diverge in dif-
ferent cell types, depending on the cargo or other burden
in each particular cell.
Models of KLC1 Function In Vivo
Formally, there are four possible models for KLC func-
tion. The first, the KLC inhibition model, is that KLC neg-
atively regulates KHC function. This model is supported
by indirect work suggesting that the enzymatic ATPase ac-
tivity of KHC is enhanced upon removal of its tail or KLC
(Kuznetsov et al., 1989; Hackney et al., 1991; Hackney,
1994; Jiang and Sheetz, 1995). This model is also sup-
ported by recent studies indicating that KLC inhibits KHC
from binding microtubules at physiologic pH, however,
shift of pH to 6.8 releases this inhibition (Verhey et al.,
1998). Interestingly, in a transient transfection system in
COS cells, the coiled-coil domain of KLC by itself was ca-
pable of binding KHC and causing this inhibitory effect.
These studies also suggested that excess KHC by itself, in
the absence of coexpressed KLC, would translocate along
microtubules to the periphery of the cell. Our observations
are not entirely consistent with this study and do not
readily support the KLC inhibition model. We do not ob-
serve accumulation of the KIF5A or KIF5B KHC chains
at the cellular periphery or on filamentous elements in the
cytoplasm of KLC1 mutant neurons. Instead, we see accu-
mulations in or near the Golgi apparatus of KIF5A and
punctate accumulations of KIF5B associated with COPI.
It is possible that these observational differences can be
explained by the fact that COS cells are not neurons; fur-
ther work is needed to uncover the source of this discrep-
ancy. The KLC inhibition model is also inconsistent with
previous data suggesting that kinesin-I in Neurospora
(Steinberg and Schliwa, 1995) and sea urchin (Skoufias et
al., 1994) may not require stoichiometric amounts of KLC.
The second model of KLC function, the KLC attach-
ment model, suggests that KLC is required for general at-
tachment to cargo. This model is supported by recent work
(Stenoien and Brady, 1997) showing that perfusion of
squid axoplasm with an mAb directed against the TPR do-
main of KLC significantly inhibits transport of vesicles and
organelles. Therefore, one would expect that removal of
the TPR domain in KLC1 would prevent KHC from inter-
acting properly with all potential cargoes. In this view,
KLC1 mutant mice would be expected to exhibit cellular
defects suggestive of the absence of cargo binding. In fact,
KLC1 mutant mice show accumulations of KIF5A (and
possibly KIF5B) on putative cargoes in the cell bodies of
the motor and sensory neurons.
The third model, the KLC specific targeting model, sug-
gests that KLC is required for targeting of KHC to some,
but not all cargoes. This model is supported by recent
work indicating that a particular splice form of KLC is
preferentially localized on mitochondria, but not on other
potential kinesin-I cargoes (Khodjakov et al., 1998). In
this view, our observation of abnormal accumulations of
KIF5A on or near the Golgi apparatus in KLC1 mutants
would result from absence of proper targeting, leading to
improper targeting to the Golgi apparatus. However, the
observation that faint but detectable KIF5A is seen in or
near the Golgi apparatus in wild-type neurons, coupled to
many previous observations of kinesin-I in associationThe Journal of Cell Biology, Volume 146, 1999 1286
with Golgi elements in a variety of cell types (Marks et al.,
1994; Lippincott-Schwartz et al., 1995; Johnson et al.,
1996), suggests that the Golgi region is a normal site of
KIF5A binding.
The fourth and final model, which is the model we favor
at present, is the KLC activation model. This model sug-
gests that KLC is required to activate KHC after proper
cargo binding. This model is consistent with data in Dro-
sophila demonstrating that KLC is essential for kinesin-I
function (Gindhart et al., 1998), and is also supported by
our observation that in the absence of functional KLC1,
KIF5A accumulates at a site of presumed transport initia-
tion in or near the Golgi apparatus. In fact, several previ-
ous experiments suggest that there is a normal association
of some kinesin-I with elements of the Golgi apparatus,
perhaps because kinesin-I plays some role in transport ini-
tiating at the Golgi apparatus (Marks et al., 1994; Lippin-
cott-Schwartz et al., 1995; Johnson et al., 1996). Under this
view, KIF5B is also accumulating at a presently unidenti-
fied site of transport initiation in KLC1 mutants. This
model can also accommodate the suggestion (Verhey et al.,
1998) that cargo binding is required for activation of the
kinesin-I holoenzyme by either causing pH shift or small
conformation changes. Further work on cells cultured
from these mutant animals and permeabilized cell systems
may help to test this model, and to understand the details
of the proposed activation that is revealed by the KLC1
mutant.
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